|
Model Number SMEC10R |
Device Problems
Break (1069); Positioning Failure (1158); Difficult to Remove (1528); Detachment of Device or Device Component (2907)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/15/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
As the lot number for the device was not provided, a review of the device history records could not be performed.The device has been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.
|
|
Event Description
|
It was reported that some time post breast biopsy marker placement, the device allegedly had a positioning failure and was difficult to be removed after the procedure.Another marker was used to complete the procedure, but unsuccessful.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a manufacturing review was not requested as the lot number reported as unknown.Investigation summary: one senomark biopsy marker applicator was returned for evaluation.During visual evaluation, the biopsy marker appeared to have blood residue.The wire-form marker and pads were not present in the returned applicator.Functional testing was not conducted due to the returned device condition.Then, the biopsy applicator tip was x-rayed, and it was noted the marker was not present.The pva pads that were removed from the encor probe were x-rayed and it was noted the marker was present.Therefore, the investigation is confirmed for the reported positioning failure as markers were present in the returned device.However, the investigation is inconclusive for the reported difficult to remove as functional testing was not performed.A definitive root cause for the alleged positioning failure and difficult to remove could not be determined based upon the provided information.Labeling review: the review of the instructions for use, indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.H10: g3, h6 (method).H11: h6 (result, conclusion).H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : see h10.
|
|
Event Description
|
It was reported that the device allegedly had a positioning failure and the device was difficult to be removed after the procedure.There was no reported patient injury.
|
|
Event Description
|
It was reported that during the procedure the device allegedly was difficult to remove.It was further reported that the marker allegedly had positioning failure.There was no reported patient injury.
|
|
Manufacturer Narrative
|
H10: manufacturing review: a manufacturing review was not requested as the lot number reported as unknown.Investigation summary: one senomark biopsy marker applicator was returned for evaluation.During visual evaluation, the biopsy marker appeared to have blood residue.The applicator tip was detached from the applicator body and the delivery tube was stretched and kinked throughout.The wire-form marker and pads were not present in the returned applicator.The biopsy applicator tip was x-rayed, and it was noted the marker was not present.The pva pads were found in the returned encor probe aperture behind blockage.Therefore, based on the received condition of the sample the investigation is confirmed for positioning failure, difficulty removing the applicator from the probe, a broken wireform, and detached applicator tip.Based upon the reported information and the returned sample condition (detached applicator tip, stretching of the applicator tubing) the identified detachment and break are consistent with excessive force used to remove a stuck applicator.The definitive root causes for the deployment and removal issues are unknown.Labeling review: the review of the instructions for use, indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Search Alerts/Recalls
|
|
|